https://www.zacks.com/stock/news/2246671/why-cigna-ci-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2246671
Mar 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:4686581937090686336
0
https://www.zacks.com/stock/news/2245868/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245868
Mar 26, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
zc:8450830302829201057
0
https://www.zacks.com/stock/news/2243009/unitedhealth-unh-to-roll-out-medical-claims-software-soon?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243009
Mar 19, 2024 - UnitedHealth (UNH) assists care providers with more than $2 billion through several initiatives to mitigate the cash flow crunch arising from the cyberattack.
zc:310997169596993942
0
https://www.zacks.com/stock/news/2242211/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242211
Mar 18, 2024 - Robust growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
zc:-1394800378819239604
0
https://www.zacks.com/commentary/2241645/are-these-3-beaten-down-s-p-500-members-worth-a-look?cid=CS-ZC-FT-investment_ideas-2241645
Mar 15, 2024 - The market has enjoyed a fantastic run in 2024, building nicely on last year???s gains. But not all have joined the party, specifically these three. Deep in the red year-to-date, are they worth a look?
zc:805452970517679529
0
https://www.zacks.com/stock/news/2241626/why-elevance-elv-is-a-smart-addition-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2241626
Mar 15, 2024 - Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.
zc:4632802020192979914
0
https://www.zacks.com/stock/news/2238726/the-joint-jynt-rises-30-as-q4-earnings-beat-on-higher-clinics?cid=CS-ZC-FT-analyst_blog|earnings_article-2238726
Mar 11, 2024 - The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.
zc:-3074900321980877607
0
https://www.zacks.com/stock/news/2238612/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2238612
Mar 11, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:-102267631983454407
0
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
zc:251403302678507286
0
https://www.zacks.com/stock/news/2236168/hca-healthcare-hca-rises-24-8-in-a-year-more-room-to-run?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2236168
Mar 05, 2024 - HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.
zc:7583634116453664241
0